ClinConnect ClinConnect Logo
Search / Trial NCT06624540

Impact of Implementing Evidence-based Practice and Nurse's Behavior Change to Improve Quality of Care in Intensive Care Unit in a Tertiary Hospital in Bangladesh

Launched by HIROSHIMA UNIVERSITY · Oct 1, 2024

Trial Information

Current as of July 01, 2025

Not yet recruiting

Keywords

Evidence Based Practice Ventilator Associated Pneumonia Nurses Knowledge

ClinConnect Summary

This clinical trial is studying how to improve the quality of care for patients in the Intensive Care Unit (ICU) in Bangladesh, particularly focusing on preventing ventilator-associated pneumonia (VAP), a common infection that can occur in ICU patients. The researchers want to see if training nurses to use evidence-based practices (EBP) and new equipment can lead to better patient outcomes. They will evaluate the effects of this training on nurses' behaviors and the overall health of the patients in the ICU.

To be eligible for participation, registered nurses in Bangladesh who agree to take part in the EBP training can join. Patients who are admitted to the ICU and require intubation (a procedure where a tube is placed to help them breathe) may also be included if their legal guardians give consent. Participants can expect to be part of a study where they will receive better training and support to help improve patient care. It's important to note that this trial is not yet recruiting participants, and those who stay in the ICU for less than two days or do not require ongoing care will not be included.

Gender

ALL

Eligibility criteria

  • Study 2:
  • Inclusion criteria:
  • Who will be a registered nurse in Bangladesh.
  • Who will agree to participate in this study and the EBP training.
  • Exclusion criteria:
  • Who will not directly involve patient care in ICU.
  • Study 3:
  • Inclusion Criteria:
  • Irrespective of age and sex
  • Legal guardian of a patient consents to participation in the study
  • Intubated patients after admission.
  • Exclusion Criteria:
  • Who stays less than 2 days at the GICU.
  • Who dies or is extubated within 2 days after admitted in the GICU.
  • ICU readmission.

About Hiroshima University

Hiroshima University is a prestigious research institution in Japan, renowned for its commitment to advancing medical science and improving healthcare outcomes. With a strong focus on innovative clinical research, the university actively sponsors clinical trials aimed at developing novel therapies and enhancing patient care. Its multidisciplinary approach leverages expertise across various fields, fostering collaboration among researchers, clinicians, and industry partners. Through rigorous study design and adherence to ethical standards, Hiroshima University strives to contribute valuable insights to the global medical community while ensuring the highest level of participant safety and welfare.

Locations

Dhaka, , Bangladesh

Hiroshima, Kasumi 1 2 3 Minami Ku, Japan

Hiroshima, , Japan

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported